OBJECTIVES: The purpose of this study was to examine the association between prolongation of QT interval corrected for heart rate (QTc) with incident stroke. BACKGROUND: Unlike cardiovascular morbidity and mortality, little is known about the relationship between QTc and risk of stroke. METHODS: A total of 27,411 participants age 45 years and older without previous stroke from the REGARDS (REasons for Geographic and Racial Differences in Stroke) study were included in this analysis. QTc was calculated using Framingham formula (QTc(Fram)). Stroke cases were identified and adjudicated during up to 8.2 years of follow-up (median, 5.1 years). RESULTS: The risk of incident stroke in study participants with prolonged QTc(Fram) was almost 3 times the risk in those with normal QTc(Fram) (hazard ratio [HR] [95% confidence interval (CI)]: 2.88 [2.12 to 3.92], p < 0.0001). After adjustment for demographics (age, race, and sex), traditional stroke risk factors (antihypertensive medication use, systolic blood pressure, current smoking, diabetes, left ventricular hypertrophy, atrial fibrillation, and previous cardiovascular disease), warfarin use, aspirin use, QRS duration and use of QTc-prolonging drugs, the risk of stroke remained significantly high (HR [95% CI]: 1.67 [1.16 to 2.41], p = 0.0061) and was consistent across several subgroups of REGARDS study participants. Similar results were obtained when the risk of stroke was estimated per 1-SD increase in QTc(Fram), (HR [95% CI]: 1.12 [1.03 to 1.21], p = 0.0053 in multivariable-adjusted model) and when other QTc correction formulas including those of Hodge, Bazett, and Fridericia were used. CONCLUSIONS: QTc prolongation is associated with a significantly increased risk of incident stroke independent of traditional stroke risk factors. Examining the risk of stroke associated with QTc-prolonging drugs may be warranted.
OBJECTIVES: The purpose of this study was to examine the association between prolongation of QT interval corrected for heart rate (QTc) with incident stroke. BACKGROUND: Unlike cardiovascular morbidity and mortality, little is known about the relationship between QTc and risk of stroke. METHODS: A total of 27,411 participants age 45 years and older without previous stroke from the REGARDS (REasons for Geographic and Racial Differences in Stroke) study were included in this analysis. QTc was calculated using Framingham formula (QTc(Fram)). Stroke cases were identified and adjudicated during up to 8.2 years of follow-up (median, 5.1 years). RESULTS: The risk of incident stroke in study participants with prolonged QTc(Fram) was almost 3 times the risk in those with normal QTc(Fram) (hazard ratio [HR] [95% confidence interval (CI)]: 2.88 [2.12 to 3.92], p < 0.0001). After adjustment for demographics (age, race, and sex), traditional stroke risk factors (antihypertensive medication use, systolic blood pressure, current smoking, diabetes, left ventricular hypertrophy, atrial fibrillation, and previous cardiovascular disease), warfarin use, aspirin use, QRS duration and use of QTc-prolonging drugs, the risk of stroke remained significantly high (HR [95% CI]: 1.67 [1.16 to 2.41], p = 0.0061) and was consistent across several subgroups of REGARDS study participants. Similar results were obtained when the risk of stroke was estimated per 1-SD increase in QTc(Fram), (HR [95% CI]: 1.12 [1.03 to 1.21], p = 0.0053 in multivariable-adjusted model) and when other QTc correction formulas including those of Hodge, Bazett, and Fridericia were used. CONCLUSIONS:QTc prolongation is associated with a significantly increased risk of incident stroke independent of traditional stroke risk factors. Examining the risk of stroke associated with QTc-prolonging drugs may be warranted.
Authors: J F Meschia; T G Brott; F E Chukwudelunzu; J Hardy; R D Brown; I Meissner; L J Hall; E J Atkinson; P C O'Brien Journal: Stroke Date: 2000-05 Impact factor: 7.914
Authors: Martin K Rutter; Sathyamurthy Viswanath; Janet M McComb; Patrick Kesteven; Sally M Marshall Journal: Clin Auton Res Date: 2002-10 Impact factor: 4.435
Authors: Jacqueline M Dekker; Richard S Crow; Peter J Hannan; Evert G Schouten; Aaron R Folsom Journal: J Am Coll Cardiol Date: 2004-02-18 Impact factor: 24.094
Authors: Stuart J Connolly; A John Camm; Jonathan L Halperin; Campbell Joyner; Marco Alings; John Amerena; Dan Atar; Álvaro Avezum; Per Blomström; Martin Borggrefe; Andrzej Budaj; Shih-Ann Chen; Chi Keong Ching; Patrick Commerford; Antonio Dans; Jean-Marc Davy; Etienne Delacrétaz; Giuseppe Di Pasquale; Rafael Diaz; Paul Dorian; Greg Flaker; Sergey Golitsyn; Antonio Gonzalez-Hermosillo; Christopher B Granger; Hein Heidbüchel; Josef Kautzner; June Soo Kim; Fernando Lanas; Basil S Lewis; Jose L Merino; Carlos Morillo; Jan Murin; Calambur Narasimhan; Ernesto Paolasso; Alexander Parkhomenko; Nicholas S Peters; Kui-Hian Sim; Martin K Stiles; Supachai Tanomsup; Lauri Toivonen; János Tomcsányi; Christian Torp-Pedersen; Hung-Fat Tse; Panos Vardas; Dragos Vinereanu; Denis Xavier; Jun Zhu; Jun-Ren Zhu; Lydie Baret-Cormel; Estelle Weinling; Christoph Staiger; Salim Yusuf; Susan Chrolavicius; Rizwan Afzal; Stefan H Hohnloser Journal: N Engl J Med Date: 2011-11-14 Impact factor: 91.245
Authors: Lisandro D Colantonio; Usman Baber; Maciej Banach; Rikki M Tanner; David G Warnock; Orlando M Gutiérrez; Monika M Safford; Christoph Wanner; George Howard; Paul Muntner Journal: J Am Soc Nephrol Date: 2014-11-13 Impact factor: 10.121
Authors: Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford Journal: JAMA Date: 2014-04-09 Impact factor: 56.272
Authors: Marguerite R Irvin; John N Booth; Daichi Shimbo; Daniel T Lackland; Suzanne Oparil; George Howard; Monika M Safford; Paul Muntner; David A Calhoun Journal: J Am Soc Hypertens Date: 2014-03-15
Authors: Heather N Anderson; J Martijn Bos; Kristina H Haugaa; Bruce W Morlan; Robert F Tarrell; Pedro J Caraballo; Michael J Ackerman Journal: Pediatr Cardiol Date: 2015-04-07 Impact factor: 1.655
Authors: Wesley T O'Neal; Virginia J Howard; Dawn Kleindorfer; Brett Kissela; Suzanne E Judd; Leslie A McClure; Mary Cushman; George Howard; Elsayed Z Soliman Journal: Europace Date: 2015-10-20 Impact factor: 5.214
Authors: Wesley T O'Neal; Jimmy T Efird; Hooman Kamel; Saman Nazarian; Alvaro Alonso; Susan R Heckbert; W T Longstreth; Elsayed Z Soliman Journal: Clin Res Cardiol Date: 2015-03-10 Impact factor: 5.460